This study evaluated the impact of traditional Chinese medicine (TCM) Liangfu Pills administered via acupoint plaster in patients with type 2 diabetes mellitus (T2DM) initiating GLP-1 receptor agonist therapy. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.